Consolidated Statement Of Cash Flows

KYORIN Pharmaceutical Co., Ltd. - Filing #7739072

Concept 2016-04-01 to
2017-03-31
As at
2017-03-31
As at
2016-03-31
2015-04-01 to
2016-03-31
As at
2015-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
19,804,000,000 JPY
15,338,000,000 JPY
Interest and dividends received
381,000,000 JPY
320,000,000 JPY
Interest paid
-29,000,000 JPY
-17,000,000 JPY
Income taxes paid
-3,769,000,000 JPY
-4,504,000,000 JPY
Net cash provided by (used in) operating activities
16,386,000,000 JPY
11,137,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-2,208,000,000 JPY
-6,812,000,000 JPY
Proceeds from sale of property, plant and equipment
89,000,000 JPY
2,066,000,000 JPY
Net cash provided by (used in) investing activities
-13,142,000,000 JPY
650,000,000 JPY
Purchase of investment securities
-16,600,000,000 JPY
-8,008,000,000 JPY
Other, net
-26,000,000 JPY
-202,000,000 JPY
Cash flows from financing activities
Dividends paid
-4,322,000,000 JPY
-3,876,000,000 JPY
Proceeds from long-term borrowings
916,000,000 JPY
2,853,000,000 JPY
Repayments of long-term borrowings
-1,153,000,000 JPY
-764,000,000 JPY
Net cash provided by (used in) financing activities
-5,721,000,000 JPY
-2,245,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
-65,000,000 JPY
-226,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-2,543,000,000 JPY
9,315,000,000 JPY
Cash and cash equivalents
42,499,000,000 JPY
45,043,000,000 JPY
35,727,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.